Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-19

Clinical Trial Update: Safety and Efficacy of Modulated Ultrasound Renal Denervation for HTN(FIM) [NA]

View source ↗

Summary

A clinical trial evaluating the safety and efficacy of modulated ultrasound renal denervation for essential hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Modulated Ultrasound Renal Denervation

Snippet

Sponsor: Shenzhen Pulsecare Medical Technology Co., Ltd. | Conditions: Essential Hypertension | NA | Status: RECRUITING